HCPCS J0605 is officially defined as "Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)." HCPCS J0605 is referenced in 6 tracked payer policy changes from Blue Cross Blue Shield of North Dakota, Indiana Medicaid (IHCP), and 3 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0605 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Blue Cross Blue Shield of North Dakota's August 2026 pharmacy update covers Medicaid Expansion medical drug prior authorization policies, with new policies and coding changes effective October 1, 2026. The most important billing change is the new HCPCS codes that replace older codes, such as Q5172 for Filkri and J9362 for Yondelis, plus added diagnosis codes for several drugs; the commercial pharmacy policies were reviewed with no changes listed.
Indiana Health Coverage Programs (IHCP) removed three ESRD drug codes (J0605, J0609, J0911) from the renal dialysis composite rate, effective immediately with retroactive application. These codes will now be separately reimbursed when billed with proper documentation and NDC information for ESRD patients receiving outpatient dialysis.
Aetna is implementing multiple prior authorization changes for specialty drugs and procedures, removing precertification requirements for artificial insemination procedures, and requiring valid CPT/HCPCS codes for behavioral health services. Key changes take effect at various dates from November 2025 through February 2026.
Nevada Medicaid has opened 23 new pharmacy-related HCPCS codes for billing on physician-administered drug (PAD) claims, effective June 1, 2026. All claims using these codes must include a National Drug Code (NDC) and no automatic reprocessing will occur.
Three HCPCS codes (J0605, J0609, J0911) for ESRD drugs are now included in the renal dialysis composite rate and cannot be billed separately for dialysis patients. This change is effective immediately and retroactive to the original CMS effective dates for each code.
Already effective July 1, 2025, Louisiana Blue accepts only the CAQH application for professional credentialing and recredentialing, and the Louisiana Standardized Credentialing Application was accepted for participating providers until June 30. Added codes in the Diagnostic and Therapeutic Services and Outpatient Procedure Services code ranges have effective dates of January 1, 2025 and April 1, 2025, including 15013, 15014, 38226 and 38227. For infusion therapy, the prior authorization must include all codes billed, including administration codes, or penalties will be applied to the claim.
Watch J0605
Get one email when a payer policy names J0605, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for J0605
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J0605 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.